NewsRx

Search our medical news database

Conference Coverage (IHV)

Novel Chemokine Seen As Lead Molecule for AIDS Therapy

Published in Vaccine Weekly, September 6th, 1999

A newly discovered chemokine may be the key to a new class of AIDS therapies.

HIV must use cellular chemokine receptors to infect cells. Natural chemokines block HIV infection. For several years, HIV co-discoverer Robert C. Gallo has advocated taking advantage of this fact by creating chemokine-based therapies.

Recently, Anthony DeVico, Gallo, and colleagues at the Institute of Human Virology showed that a novel chemokine known as macrophage-derived chemokine (MDC) can block infection by HIV strains that use either of the two chemokine receptors used for viral entry (CCR5 and CXCR4).

"Our more recent studies reveal that MDC is...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook